Description
Used in the treatment of:
- Bone metastases from solid tumors
- Giant cell tumor of bone
Denosumab binds RANKL to inhibit osteoclast formation and function, reducing bone complications in metastatic cancers.
Support Email: info@biomedspecialitypharma.com
PRODUCT SPECIFICATION
Strength / Dose: 120 mg per vial or prefilled syringe
Dosage Form: Solution for subcutaneous injection
Packing Type: Prefilled syringe or vial packed in carton
Treatment:
Used in the treatment of:
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Denosumab
Brand: Esentra 120
Used in the treatment of:
PRODUCT SPECIFICATION
Strength / Dose: 150 mg per vial
Dosage Form: Lyophilized powder for injection (for subcutaneous or intravenous use after reconstitution)
Packing Type: Glass vial with rubber stopper & aluminium seal, packed in carton
Treatment:
Used in the treatment of:
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Azacitidine
Brand: Azadine 150
PRODUCT SPECIFICATION
Strength / Dose: 200 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets in blister or bottle, packed in carton
Treatment: Used in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) in appropriate patient populations (as per local/regional approval)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Azacitidine
Brand: Azatend-O
Our global distribution network and regulatory expertise enable us to deliver world-class pharmaceutical products that meet local market needs.
Address: DGS Sheetal Regalia, 209, Nensey Colony, Borivali East, Mumbai, Maharashtra 400066
Support mail: info@biomedspecialitypharma.com
Opening Hours: Monday – Saturday: 10.00am – 08.00pm